Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Gastrointestinal Cancers
Do you use adjuvant radiation therapy for low grade biliary neuroendocrine cancer with positive margin?
Answer from: Radiation Oncologist at Academic Institution
Yes.
Sign In
or
Register
to read more
11858
Related Questions
Would you alter your approach in using neoadjuvant radiation for a rectal cancer patient who has had a prior radical prostatectomy but no prior pelvic radiation?
What if any, is your radiation approach to treating hepatic metastases abutting/invading luminal GI structures?
In a patient with gastroesophageal adenocarcinoma treated with neoadjuvant chemoimmunotherapy who had a good response but is unable to undergo surgery, how would you approach radiation therapy?
What adjuvant treatment approach would you recommend for a patient with early-stage MSI-high gastric cancer who received neoadjuvant ipilimumab (×2) and nivolumab (×6) per the NEONIPIGA regimen, followed by R0 resection with no pathologic response?
What are your institutions' preferences on SBRT vs. histotripsy for treatment of liver metastases?
How would you treat a patient with cervical esophageal squamous cell carcinoma, as second primary, many years after radiation therapy with chemotherapy for Hodgkin’s disease?
How would you plan adjuvant radiation for an incidental gallbladder carcinoma after cholecystectomy, pT2 with negative margins, now s/p partial hepatectomy and lymphadenectomy with positive nodal disease in a patient who could not tolerate systemic therapy?
Would you modify the postoperative radiation dose to a pancreas tumor bed in the setting of a remote history of prior abdominal RT, specifically with regard cumulative small bowel dose?
How would you treat a painful peripancreatic schwannoma in the setting of prior SBRT course?
Would you offer any adjuvant therapy for a young patient with anal cancer s/p definitive chemoradiation and R0 resection with significant residual disease?